Contact Us

Cardiosense receives FDA Breakthrough Device designation for algorithm to identify patients at risk of decompensated heart failure

Investigational Device. Limited by Federal (or United States) Law to Investigational Use

© Copyright 2022 by Cardiosense. All Rights Reserved
Linkedin-in Twitter

400 N Aberdeen St Suite 900
Chicago, IL 60642

[email protected]

© Copyright 2022 by Cardiosense. All Rights Reserved